that is a huge difference. you have been monitoring those people in the study, how important do you think the results could be here? i study, how important do you think the results could be here?- the results could be here? i think these are quite the results could be here? i think these are quite significant. - these are quite significant. essentially, this results, it indicates that the fact that we can neutralise indicates that the fact that we can neutralise new variance better with this combination of antibiotic results. this combination of antibiotic results, it means that it has significant impact for the future of the epidemic because as you vaccinate the epidemic because as you vaccinate more and more people around vaccinate more and more people around the vaccinate more and more people around the world, and as more people acquire around the world, and as more people acquire natural infection, we will have acquire natural infection, we will have an acquire na
of the olympics might have something to do with it. xi an isn t that far to the west of beijing and they ve seen omicron taking off in other parts of the world and itjust shows what china is prepared to do with its still sticking to the back to zero covid strategy. fascinating research from the us, scientists have been studying immunity levels for those that have been double vaccinated and then caught coronavirus. their findings have been raising eyebrows and it could have significant implications. let s speak to the report authors, from the oregon health and science university. thanks forjoining us. this is really interesting stuff. i was reading the details earlier. professor, what have you found out about immunity among the double
welcomed by the prime minister, naftali bennett. he had previously said he was impatient for the green light to be given for this. he described it has wonderful news and immediately started preparations for that fourth shot to be given to those people. there is still a bit of rubber stamping to do by the health ministry, but it looks like it will go ahead. now, the issue here, as you say, is very much about data. what is the data behind this? we simply don t know, because the expert committee have not published the evidential basis for all of this. and one of the experts involved in the decision was on the radio in israel saying that they simply do not have the information, they don t have the numbers yet for whether or not immunity wanes after the third vaccine, and if it does, how long it takes, and by how much. she described that has quite a complex decision, and said, nevertheless, when you look at the way that omicron is spreading, its infectiousness elsewhere in the world, she de
you make. what does that tell i along. interesting, the last point i you make. what does that tell you about omicron and future variance? are you sure that what you have discovered here will actually impact in variants that have to be established? its in variants that have to be established? in variants that have to be established? , ., , ., established? its a good question. what we saw established? its a good question. what we saw with established? its a good question. what we saw with our established? its a good question. what we saw with our previous i established? its a good question. i what we saw with our previous study is when what we saw with our previous study is when you what we saw with our previous study is when you have combined immunity from natural is when you have combined immunity from natural infection and vaccination, and you take that sarurn, vaccination, and you take that sarum, and you compare that with those sarum, and you compare that with those